3D MEDICINES (01244): Liang Jingjing has been appointed as the agent for legal process documents.
Siqudi Pharmaceutical Co., Ltd. (01244) announced that Ms. Liang Jingjing has been appointed to replace Ms. Li Jingyi as the agent to receive legal proceedings and notices on behalf of the company in Hong Kong, effective from August 4, 2026.
3D MEDICINES (01244) announced that Ms. Liang Jingjing has been appointed to replace Ms. Li Jingyi as the agent for the company to receive legal documents and notifications in Hong Kong, effective from August 4, 2026.
Related Articles
KINETIC DEV(01277): The Makhado project has officially started production.
TONTINE WINES (00389) rejects the proposal for the major shareholder Wang Hexin to subscribe for new shares.
US Stock Market Move | SpaceX (SPCX.US) rises 4% as its first quarterly report since going public is about to be released.
KINETIC DEV(01277): The Makhado project has officially started production.
TONTINE WINES (00389) rejects the proposal for the major shareholder Wang Hexin to subscribe for new shares.
US Stock Market Move | SpaceX (SPCX.US) rises 4% as its first quarterly report since going public is about to be released.
RECOMMEND
